Exchange Traded Concepts, LLC Vertex Pharmaceuticals Inc Transaction History

Exchange Traded Concepts, LLC

$4.18 Billion
Q3 2024

A detailed history of Exchange Traded Concepts, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 2,958 shares of VRTX stock, worth $1.49 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,958

Previous 5,313 44.33%

Holding current value

$1.49 Million

Previous $2.49 Million 44.78%

% of portfolio

0.03%

Previous 0.06%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$460.0 - $505.78 $1.08 Million - $1.19 Million	-2,355 Reduced 44.33%	2,958 $1.38 Million
Q2 2024 Aug 13, 2024	SELL	$392.81 - $485.53 $50,279 - $62,147	-128 Reduced 2.35%	5,313 $2.49 Million
Q1 2024 Apr 15, 2024	SELL	$407.69 - $446.08 $945,025 - $1.03 Million	-2,318 Reduced 29.87%	5,441 $2.27 Million
Q4 2023 Jan 05, 2024	SELL	$343.0 - $410.68 $470,253 - $563,042	-1,371 Reduced 15.02%	7,759 $3.16 Million
Q3 2023 Oct 18, 2023	BUY	$338.18 - $362.46 $270,205 - $289,605	799 Added 9.59%	9,130 $3.17 Million
Q2 2023 Jul 20, 2023	SELL	$314.42 - $351.91 $605,572 - $677,778	-1,926 Reduced 18.78%	8,331 $2.93 Million
Q1 2023 Apr 12, 2023	BUY	$283.23 - $323.1 $498,768 - $568,979	1,761 Added 20.73%	10,257 $3.23 Million
Q4 2022 Jan 17, 2023	SELL	$285.76 - $321.48 $682,966 - $768,337	-2,390 Reduced 21.95%	8,496 $2.45 Million
Q3 2022 Oct 07, 2022	SELL	$273.83 - $305.53 $237,410 - $264,894	-867 Reduced 7.38%	10,886 $3.15 Million
Q2 2022 Jul 20, 2022	SELL	$234.96 - $292.55 $540,173 - $672,572	-2,299 Reduced 16.36%	11,753 $3.31 Million
Q1 2022 Apr 26, 2022	BUY	$221.42 - $260.97 $429,997 - $506,803	1,942 Added 16.04%	14,052 $3.67 Million
Q4 2021 Jan 13, 2022	SELL	$177.01 - $223.45 $592,275 - $747,663	-3,346 Reduced 21.65%	12,110 $2.66 Million
Q3 2021 Oct 18, 2021	SELL	$181.39 - $202.99 $2.03 Million - $2.28 Million	-11,217 Reduced 42.05%	15,456 $2.8 Million
Q2 2021 Jul 30, 2021	BUY	$187.49 - $221.1 $2.94 Million - $3.46 Million	15,666 Added 142.33%	26,673 $5.38 Million
Q1 2021 Apr 20, 2021	BUY	$207.02 - $241.31 $855,406 - $997,092	4,132 Added 60.1%	11,007 $2.37 Million
Q4 2020 Jan 19, 2021	BUY	$207.01 - $276.09 $924,920 - $1.23 Million	4,468 Added 185.63%	6,875 $1.63 Million
Q3 2020 Oct 30, 2020	BUY	$255.65 - $303.1 $270,733 - $320,982	1,059 Added 78.56%	2,407 $655,000
Q2 2020 Jul 15, 2020	BUY	$225.48 - $295.8 $184,668 - $242,260	819 Added 154.82%	1,348 $391,000
Q1 2020 Apr 14, 2020	BUY	$199.77 - $247.81 $20,176 - $25,028	101 Added 23.6%	529 $126,000
Q4 2019 Jan 22, 2020	BUY	$166.71 - $223.91 $71,351 - $95,833	428 New	428 $94,000

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Account

Exchange Traded Concepts, LLC Vertex Pharmaceuticals Inc Transaction History